Alexey V. Eliseev

Founded in 2003, Maxwell Asset Management LLC is a venture capital firm located in Boston. The firm is a subsidiary of Moscow-based Maxwell Capital Group LLC. They manage the Maxwell Biotech Venture Fund, Russia's first venture fund focused on the medical and biotechnology sectors. The fund is one of the first venture funds formed with the participation of the Russian Venture Company (RVC), a fund-of-funds created by the Russian government to promote the development of the venture capital industry and an innovation-based economy.

Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA.

MirImmune, Inc. is a biopharmaceutical company that develops new generation immunotherapies for cancer. It combines two approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies. The company was founded by Alexey V. Eliseev, Alexey Wolfson, and Timothy Joseph Barberich on May 18, 2015 and is headquartered in Boston, MA.

Bionevia Pharmaceuticals, Inc. operates as a chronic disease hospital. Timothy Joseph Barberich has been the CEO of the American company since 2008.

Alantos Pharmaceuticals AG develops and manufactures molecule pharmaceuticals for arthritic and metabolic diseases. The company was founded in 1999 and is headquartered in Heidelberg, Germany.

Boston BioCom LLC develops and commercializes life science technologies. The company was founded by Alexey V. Eliseev in 2007 is headquartered in Boston, MA.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.